Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.08% Nasdaq Down 0.83%
Streaming
Ticker Tape: On

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
6.39 Down 0.39(5.75%) Apr 23, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:6.78
Open:6.58
Bid:6.32 x 1500
Ask:6.63 x 1000
1y Target Est:15.25
Beta:-0.520
Next Earnings Date:N/A
Day's Range:6.31 - 6.62
52wk Range:5.76 - 15.67
Volume:395,016
Avg Vol (3m):457,731
Market Cap:99.88M
P/E (ttm):N/A
EPS (ttm):-0.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Reports

Comparison

Symbol% ChgMkt Cap
CNATDown 5.75%99.88M
GALTDown 1.79%265.38M
ICPTDown 6.89%5.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.79
Quarterly EPS Est (Mar-14) :-0.33
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-3.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback